InvestorsHub Logo

cowtown jay

12/15/21 11:13 AM

#34611 RE: drifter #34608

Preciouslife1 shared a very good article with us on XBI and IBB a couple days ago. Regarding these two ETF's there was this info.

https://seekingalpha.com/amp/article/4473584-ibb-and-xbi-four-reasons-to-buy-biotech-stocks-ahead-of-2022

"Here are some interesting data regarding the biotech space right now:

100 stocks are trading below the cash they have on their balance sheets.
210 stocks are trading with a cash/market-cap ratio <2.
447 stocks are trading at oversold territory (i.e. RSI <30).
Basically, buying biotechs right now is the equivalent of buying cash, and in many cases you get more than $1 of cash for every $1 you put into this space.

Using the XBI/SPY, you can see that not only is the ratio at the lowest level in about 8.5 years, but it's around the same level it was at the bottom of the subprime crisis...

4. A negative year is usually followed by a very good year

4 "Negative" years (total return <0% and >-20%), each of those with a double-digit negative returns.
7 "Very Positive" years (total return 20%+ total return).
4 "Positive" years (total return >0% and <20%), all of those a decade or more ago.
Not a single "Very Negative" year (total return <-20%) been recorded.
Over the past decade (2012 on), after each of the two negative years came a "Very Positive" year, with an average return of 30.66%.
Over the past 20 years (2002 on), there was no case of two consecutive negative years."